Multidisciplinary Education in Lung Cancer Patients Who Receiving Chemotherapy Treatment

Outcome of Multidisciplinary Education Programme in Self-care in Fatigue Lung Cancer Patients Who Receiving Chemotherapy Treatment

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01546233

Enrollment

Registered

2012-03-07

Start date

2012-03-31

Completion date

2012-12-31

Last updated

2016-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Keywords

Lung cancer, Chemotherapy, Multidisciplinary self care programme, Fatigue

Brief summary

The purpose of this study is to compare the fatigue in lung cancer patients receiving chemotherapy treatment, between the education programme in self-care a multidisciplinary with the group who received standard care.

Detailed description

Educate of self-care by Oncology nurses to relieve and prevent the fatigue of cancer chemotherapy, and provide the manual to read at home, take about 15 minutes. By using home exercise program, 30 minutes of physical education. Teaching and demonstration exercises of the muscles to breath and conservation of energy during exercise and record the exercise/walking diary, the nutritional education nutrition counseling, psychiatric assessment,self-care prevention of depression.

Interventions

BEHAVIORALmultidisciplinary education programme

BEHAVIORALstandard education

standard education before and after chemotherapy

Study design

Observational model

CASE_CONTROL

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

45 Years to 65 Years

Healthy volunteers

Inclusion criteria

1. Aged 45-65 years. 2. Has been diagnosed lung cancer stages 3-4 must be chemotherapy is platinum-based, and had received chemotherapy for at least one time, must be in the range of 2-4 cycles of chemotherapy. 3. Performance status: ECOG 0-1 4. No problem hearing it. 5. Read and write Thai. 6. Be willing to cooperate in research. And signed a joint research

Exclusion criteria

1. The complications include: high fever, severe nausea and vomiting. 2. Injection drug use in diabetes treatment. 3. Ischemic heart disease with heart arrhythmia and the drug continuously. 4. Is unable to daily living. Caused by defects in movement, and severe osteoarthritis, muscle atrophy, paralysis or walking flat less than 10 meters.

Design outcomes

Primary

Measure	Time frame
Measure fatigue by questionnaires	August 2011 to august 2012 (up to 1 year)

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026